Wells Fargo’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3
| Closed | -$31 | – | 7353 |
|
|
2025
Q3 | $31 | Buy |
+3
| New | +$26 | ﹤0.01% | 6598 |
|
|
2024
Q2 | – | Sell |
-8
| Closed | -$383 | – | 7465 |
|
|
2024
Q1 | $383 | Buy |
8
+1
| +14% | +$51 | ﹤0.01% | 6341 |
|
|
2023
Q4 | $422 | Buy |
7
+3
| +75% | +$142 | ﹤0.01% | 6424 |
|
|
2023
Q3 | $15 | Sell |
4
-2
| -33% | -$19 | ﹤0.01% | 7294 |
|
|
2023
Q2 | $99 | Buy |
6
+1
| +20% | +$25 | ﹤0.01% | 6871 |
|
|
2023
Q1 | $158 | Hold |
5
| – | – | ﹤0.01% | 6836 |
|
|
2022
Q4 | $78 | Hold |
5
| – | – | ﹤0.01% | 6860 |
|
|
2022
Q3 | $0 | Buy |
5
+2
| +67% | +$59 | ﹤0.01% | 7380 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 7498 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 7819 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 7811 |
|
|
2021
Q3 | $0 | Buy |
3
+2
| +200% | +$389 | ﹤0.01% | 7527 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7445 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7380 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7023 |
|
|
2020
Q3 | $0 | Sell |
1
-1
| -50% | -$339 | ﹤0.01% | 6906 |
|
|
2020
Q2 | $0 | Sell |
2
-82
| -98% | -$32.7K | ﹤0.01% | 6829 |
|
|
2020
Q1 | $86K | Sell |
84
-2
| -2% | -$2.92K | ﹤0.01% | 5138 |
|
|
2019
Q4 | $112K | Sell |
86
-105
| -55% | -$148K | ﹤0.01% | 5237 |
|
|
2019
Q3 | $264K | Buy |
191
+117
| +158% | +$189K | ﹤0.01% | 4792 |
|
|
2019
Q2 | $168K | Buy |
74
+70
| +1,750% | +$206K | ﹤0.01% | 5069 |
|
|
2019
Q1 | $11K | Sell |
4
-5
| -56% | -$11.1K | ﹤0.01% | 5625 |
|
|
2018
Q4 | $14K | Sell |
9
-10
| -53% | -$20.6K | ﹤0.01% | 5860 |
|
|
2018
Q3 | $40K | Buy |
19
+4
| +27% | +$9.61K | ﹤0.01% | 5659 |
|
|
2018
Q2 | $41K | Sell |
15
-147
| -91% | -$387K | ﹤0.01% | 5649 |
|
|
2018
Q1 | $384K | Buy |
162
+111
| +218% | +$333K | ﹤0.01% | 4584 |
|
|
2017
Q4 | $209K | Sell |
51
-11
| -18% | -$46.2K | ﹤0.01% | 4939 |
|
|
2017
Q3 | $259K | Buy |
62
+6
| +11% | +$25.6K | ﹤0.01% | 4773 |
|
|
2017
Q2 | $256K | Buy |
56
+12
| +27% | +$50.8K | ﹤0.01% | 4628 |
|
|
2017
Q1 | $239K | Sell |
44
-14
| -24% | -$65.2K | ﹤0.01% | 4706 |
|
|
2016
Q4 | $260K | Buy |
58
+29
| +100% | +$361K | ﹤0.01% | 4617 |
|
|
2016
Q3 | $605K | Hold |
29
| – | – | ﹤0.01% | 3842 |
|
|
2016
Q2 | $442K | Buy |
29
+3
| +12% | +$68.5K | ﹤0.01% | 3981 |
|
|
2016
Q1 | $735K | Buy |
26
+4
| +18% | +$84.5K | ﹤0.01% | 3602 |
|
|
2015
Q4 | $628K | Buy |
22
+1
| +5% | +$33K | ﹤0.01% | 3777 |
|
|
2015
Q3 | $517K | Buy |
21
+10
| +91% | +$673K | ﹤0.01% | 3918 |
|
|
2015
Q2 | $940K | Buy |
11
+3
| +38% | +$275K | ﹤0.01% | 3658 |
|
|
2015
Q1 | $811K | Buy |
8
+6
| +300% | +$799K | ﹤0.01% | 3660 |
|
|
2014
Q4 | $264K | Buy |
+2
| New | +$146K | ﹤0.01% | 4289 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 5513 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 5644 |
|
Other funds holding TPST
VVM
SM
DS
Wells Fargo's TPST Position: Q4 2025 in Review
Wells Fargo sold out of Tempest Therapeutics (TPST) in Q4 2025, closing a stake of 3 shares — an estimated $31 sold.
Wells Fargo first reported a position in TPST in Q4 2014 and held it in 39 quarters. The position peaked at $940K in Q2 2015. 21 funds tracked by Wall St. Rank hold TPST as of Q4 2025.
- Wells Fargo reported no remaining Tempest Therapeutics position as of Q4 2025 after selling out during the quarter.
- Wells Fargo sold 3 Tempest Therapeutics shares in Q4 2025, an estimated $31.
- Wells Fargo first reported a position in Tempest Therapeutics in Q4 2014 and held it in 39 quarters.
- Wells Fargo's Tempest Therapeutics position peaked at $940K in Q2 2015.
- 21 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2025.
Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.